HIKAL CHEMIC share price has zoomed 6% and is presently trading at Rs 394.3.
Meanwhile, the BSE HEALTHCARE index is at 44,179.1 (up 0.8%).
Among the top gainers in the BSE HEALTHCARE index today are Natco Pharma (up 4.1%) and FORTIS HEALTHCARE (up 2.3%).
SYNGENE INTERNATIONAL (down 1.2%) and ERIS LIFESCIENCES (down 1.1%) are among the top losers today.
Over the last one year, HIKAL CHEMIC has moved up from Rs 306.1 to Rs 394.3, registering a gain of Rs 88.2 (up 28.8%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,436.8 to 44,179.1, registering a gain of 55.4% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 132.5%), Jubilant Pharmova (up 129.5%) and GRANULES INDIA (up 120.2%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 82,001.4 (up 0.1%).
The top gainers among the BSE Sensex today are Asian Paints (up 2.4%) and Bajaj Finance (up 1.8%). The most traded stocks in the BSE Sensex are Tata Motors and MUNDRA PORT & SEZ.
In the meantime, NSE Nifty is at 25,070.0 (up 0.1%). Bajaj Auto and Asian Paints are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 67,127.1 to 82,001.4, registering a gain of 14,874.3 points (up 22.2%).
HIKAL CHEMIC net profit fell 26.1% YoY to Rs 51 million for the quarter ended June 2024, compared to a profit of Rs 69 million a year ago. Net sales rose 4.8% to Rs 4,068 million during the period as against Rs 3,880 million in April-June 2023.
For the year ended March 2024, HIKAL CHEMIC reported 11.2% decrease in net profit to Rs 696 million compared to net profit of Rs 784 million during FY23. Revenue of the company fell 11.8% to Rs 17,846 million during FY24.
The current Price to earnings ratio of HIKAL CHEMIC, based on rolling 12 month earnings, stands at 71.7.
Equitymaster requests your view! Post a comment on "HIKAL CHEMIC Gains 6%; BSE HEALTHCARE Index Up 0.8%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!